JPS63258586A - Production of pyruvic acid by fermentation - Google Patents

Production of pyruvic acid by fermentation

Info

Publication number
JPS63258586A
JPS63258586A JP9093987A JP9093987A JPS63258586A JP S63258586 A JPS63258586 A JP S63258586A JP 9093987 A JP9093987 A JP 9093987A JP 9093987 A JP9093987 A JP 9093987A JP S63258586 A JPS63258586 A JP S63258586A
Authority
JP
Japan
Prior art keywords
pyruvic acid
pyruvate
torulopsis
strain
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP9093987A
Other languages
Japanese (ja)
Other versions
JPH0740945B2 (en
Inventor
Reiko Miyata
令子 宮田
Toru Yonehara
徹 米原
Kyosuke Yomoto
四本 喬介
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP9093987A priority Critical patent/JPH0740945B2/en
Publication of JPS63258586A publication Critical patent/JPS63258586A/en
Publication of JPH0740945B2 publication Critical patent/JPH0740945B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PURPOSE:To produce pyruvic acid in high efficiency, by preparing a variant having lowered PDC activity from a microorganism capable of producing pyruvic acid and belonging to Torulopsis genus and culturing the variant in a medium. CONSTITUTION:Cell of Torulopsis glabrate IFO 0005 is treated with ethylmethane sulfonate to obtain a variant having PDC (pyruvate decarboxylase) activity lowered to <=70%, preferably <=50% of that of the mother strain, e.g. Torulopsis glabrate ACII33 (FERM BP-1424). The obtained variant strain is cultured in a medium containing carbon source, nitrogen source, inorganic salts vitamins, etc., 22-32 deg.C while controlling the pH of the medium to 3-7 with an alkali. Pyruvic acid can be separated from the cultured product.

Description

【発明の詳細な説明】 〈産業上の利用分野〉 本発明は発酵法によるピルビン酸の製造法に関するもの
である。
DETAILED DESCRIPTION OF THE INVENTION <Industrial Application Field> The present invention relates to a method for producing pyruvic acid by a fermentation method.

ピルビン酸は生体代謝の重要な中間体であり、各種医・
農薬などの有効な合成原料であるのみならず酸素法によ
るL−トリ11〜フアン、L−システィン、し−チロシ
ンなどのアミノ酸合成の主要原料である。よって安価に
製造し得れば、種々の合成原料として有用である。
Pyruvate is an important intermediate in biological metabolism, and is used by various doctors and
It is not only an effective raw material for the synthesis of agricultural chemicals, but also a main raw material for the synthesis of amino acids such as L-tri-11-fan, L-cysteine, and tyrosine by the oxygen method. Therefore, if it can be produced at low cost, it is useful as a raw material for various synthetics.

〈従来の技術〉 従来、発酵法によるピルビン酸の製造法としては、サツ
カロミセス属およびキャンデイダ属などの酵母菌とその
変異株や担子菌類または特殊なバクテリアによる方法が
知られている(特公昭57−796号公報など)。
<Prior art> Conventionally, as a method for producing pyruvic acid by fermentation, methods using yeast such as Satucharomyces and Candida, their mutant strains, basidiomycetes, or special bacteria have been known (Japanese Patent Publication No. 1983-1982). Publication No. 796, etc.).

〈発明が解決しようとする問題点〉 しかしながら、かかる従来方法はエタノールなどの副生
物が多かったり、または、収率・収量が十分でなかった
りしたため工業的に有利な方法とはいえなかった。
<Problems to be Solved by the Invention> However, such conventional methods were not industrially advantageous because they produced a large amount of by-products such as ethanol, or the yield and yield were insufficient.

く問題点を解決するための手段〉 したがって本発明者らは、上記問題点を解決することが
でき、さらに生産性の高いピルビン酸の製造方法につい
て鋭意研究した結果、トルロプシス属に属し、ピルビン
酸生産能を有する微生物のピルベートデカルボキシラー
ゼ活性(以下、PDC活性と略す)を低下させることに
より、ピルビン酸の蓄積a度、生成収率が著しく向上す
ることを見出し、本発明に到達した。
Means for Solving the Problems> Therefore, as a result of intensive research into a method for producing pyruvic acid that can solve the above problems and has higher productivity, the present inventors found that pyruvic acid, which belongs to the genus Torulopsis, The inventors have discovered that the accumulation degree and production yield of pyruvate can be significantly improved by reducing the pyruvate decarboxylase activity (hereinafter abbreviated as PDC activity) of a microorganism capable of producing it, and have arrived at the present invention.

すなわち、本発明の上記目的は、トルロプシス属に属し
、ピルビン酸生産能を有する微生物のうち、PDC活性
低下株を培養することにより培地中にピルビン酸を生成
蓄積させ、これを採取することにより達成されるのであ
る。
That is, the above object of the present invention is achieved by culturing a strain of a microorganism with reduced PDC activity among the microorganisms belonging to the genus Torulopsis and having the ability to produce pyruvate, thereby producing and accumulating pyruvate in the medium, and collecting the pyruvate. It will be done.

すなわち、本発明はトルロプシス(丁oru tops
is)属に属し、ピルビン酸生産能を有し、かつピルベ
ートデカルボキシラーゼ活性がその親株よりも低い変異
株を培養して、培養液中にピルビン酸を生成蓄積せしめ
、培養液中よりピルビン酸を採取することを特徴とする
発酵法によるピルビン酸の製造法である。
That is, the present invention relates to Torulopsis (Torulopsis).
is), which has the ability to produce pyruvate and has lower pyruvate decarboxylase activity than its parent strain, is cultured to produce and accumulate pyruvate in the culture solution, and to produce pyruvate from the culture solution. This is a method for producing pyruvic acid by a fermentation method, which is characterized by collecting pyruvic acid.

次に、本発明の詳細な説明する。Next, the present invention will be explained in detail.

本発明に用いられる変異株はトルロプシス屈に屈し、P
DC活性の低下した変異株であり、かつピルビン酸生産
能を有する変異株であればいかなるものであってもよい
The mutant strain used in the present invention is succumbing to Torulopsis flexion and P
Any mutant strain may be used as long as it has a reduced DC activity and has the ability to produce pyruvate.

本発明に用いられる変異株の代表的なものとしては、例
えばトルロプシス・グラブラータACII33 (FE
RMP−93/7)にコチン酸、チアミン、ピリドキシ
ン、ビオチン要求、PDC活性低下)が挙げられる。
Typical mutant strains used in the present invention include, for example, Torulopsis glabrata ACII33 (FE
RMP-93/7) includes cotic acid, thiamine, pyridoxine, biotin requirement, and PDC activity reduction).

この変異株は、トルロプシス・グラブラータIFO00
05にコチン酸、チアミン、ピリドキシン、ビオチン要
求)より誘導されたものでおる。
This mutant strain is Torulopsis glabrata IFO00
It is derived from cotinic acid, thiamine, pyridoxine, and biotin (requires 05).

このような変異株は、野生株にまたは親株UV照射、あ
るいはN−メチル−N′−二トローN−ニトロソグアニ
ジン処理、必るいはエチルメタンスルホネート(以下、
EMSと略す)処理などの常法により変異処理された菌
体から、酢酸を含む培地で、親株に比べ有意に生育の良
好な菌株を選定することによって1qることかできる。
Such mutant strains can be produced by treating the wild strain or the parent strain with UV irradiation, N-methyl-N'-nitro-N-nitrosoguanidine treatment, or ethyl methanesulfonate (hereinafter referred to as
1q can be obtained by selecting a strain that grows significantly better than the parent strain in a medium containing acetic acid from cells mutated by a conventional method such as EMS (abbreviated as EMS) treatment.

本発明におけるPDC活性は、超音波処理、フレンチプ
レスを用いる高圧法、その他の方法により、細胞を破壊
し、遠心分離した上澄粗酵素液を用い、ピルビン酸を基
質に、チアミンピロリン酸を補酵素として反応し、生成
したアセトアルデヒドを2.4−ジニトロフェニルヒド
ラジンと反応させ、高速液体クロマトグラフィーにより
反応したアセトアルデヒドの2,4−ジニトロフェニル
ヒドラゾンを定量分析する方法により測定される。
PDC activity in the present invention is determined by disrupting cells by ultrasonication, high pressure method using a French press, or other methods, and using a supernatant crude enzyme solution obtained by centrifugation, using pyruvate as a substrate, and supplementing thiamine pyrophosphate. It is measured by a method in which the acetaldehyde produced by reacting as an enzyme is reacted with 2,4-dinitrophenylhydrazine, and the 2,4-dinitrophenylhydrazone of the reacted acetaldehyde is quantitatively analyzed by high performance liquid chromatography.

ここで、本発明で用いられる微生物のPDC活性は親株
のPDC活性を100%として表わした場合の相対活性
で示すものとする。
Here, the PDC activity of the microorganism used in the present invention is expressed as a relative activity when the PDC activity of the parent strain is expressed as 100%.

本発明において使用するPDCの活性が親株よりも低い
菌株としては、親株を基準としてその70%以下、好ま
しくは50%以下にPDC活性が低下したものが望まし
く用いられる。
The strain used in the present invention whose PDC activity is lower than that of the parent strain is preferably one whose PDC activity is reduced to 70% or less, preferably 50% or less, of the parent strain.

たとえ、親株を基準としてその70%以下にPDCの活
性が低下していなくとも、その菌株の誘導されたもとと
なる野生株を基準としてその70%以下にPDC活性が
低下していれば、本発明と同様な効果が達成されるもの
であるので、そのような菌株を用いることは本発明の範
囲内に包含される。
Even if the PDC activity is not reduced to 70% or less of the parent strain, as long as the PDC activity is reduced to 70% or less of the wild strain from which the strain was derived, the present invention The use of such strains is within the scope of the present invention, since similar effects are achieved.

本発明で用いられる培地は発酵に通常使用される炭素源
、窒素源、無機塩類、ビタミン類などをほどよく含有す
るものであればよいが、炭素源としては、グルコースな
どの糖質、有機酸、エタノール、メタノールなどの使用
酵母菌が利用し得るものが使用される。窒素源としては
硫安、硝安、塩安、尿素、ペプトン、肉エキス、味液、
その他の有機および無機窒素化合物が使用されるが、望
ましくはアミノ酸をバランスよく含む有機窒素化合物が
よい。無機塩類としてはリン酸カリウム、硫酸マグネシ
ウム、鉄、マンガン、その他の無機塩類が用いられ、ざ
らに必要に応じてチアミン、ナイアシン、ピリドキシン
、ビオチンなどの要求ビタミン、またはこれらを含有す
る酵母エキス、コーンスチープリカー、そめ他の天然物
を添加した培地を使用すればよい。
The medium used in the present invention may contain moderate amounts of carbon sources, nitrogen sources, inorganic salts, vitamins, etc. normally used in fermentation. , ethanol, methanol, etc. that can be used by the yeast used. Nitrogen sources include ammonium sulfate, ammonium nitrate, ammonium chloride, urea, peptone, meat extract, flavor liquid,
Other organic and inorganic nitrogen compounds may be used, preferably organic nitrogen compounds containing a balanced amount of amino acids. Potassium phosphate, magnesium sulfate, iron, manganese, and other inorganic salts are used as inorganic salts. A medium supplemented with cheap liquor, soybean, or other natural products may be used.

培養中はピルビン酸の生成蓄積にともない、pI−(の
低下が起こるので炭酸カルシウム、苛性ソーダ、苛性カ
リ、アンモニアなどのアルカリで1)H3〜7に調節す
ることがピルビン酸生産には有効である。培養中の温度
は22℃〜32℃が適当である。培養終了後、系内に蓄
積したピルビン酸は常法により、単離採取することがで
きる。
During culture, pI decreases as pyruvic acid is produced and accumulated, so it is effective for pyruvic acid production to adjust it to 1) H3 to 7 with an alkali such as calcium carbonate, caustic soda, caustic potash, or ammonia. A suitable temperature during culturing is 22°C to 32°C. After completion of the culture, pyruvate accumulated in the system can be isolated and collected by a conventional method.

例えば、酸性エーテル抽出、フェニルヒドラゾン化して
沈澱単離する方法なども採用することができる。
For example, methods such as acidic ether extraction and phenylhydrazonation followed by precipitation isolation can also be employed.

く作 用〉 本発明においてPDC活性レベルを低下させることは、
ピルビン酸がアセトアルデヒドへと代謝されるのを少な
くし、グルコースからピルビン酸への変換率を高めるの
に、役立ち、そのためピルビン酸の蓄積最が増加すると
推定される。
Effect> In the present invention, reducing the PDC activity level is
It is estimated that it helps reduce the metabolism of pyruvate to acetaldehyde and increases the conversion rate of glucose to pyruvate, thereby increasing pyruvate accumulation.

〈実施例〉 以下、実施例によって本発明を具体的に説明する。<Example> Hereinafter, the present invention will be specifically explained with reference to Examples.

実施例1 A、(PDC活性活性低下数得) トルロプシス・グラブラータIFO0005にコチン酸
、チアミン、ピリドキシン、ビオチン要求)の菌体を常
法によりEMS処理(1W/V%、30℃で3時間)し
たのち、栄養寒天培地(GP寒天培地、大五栄養化学株
式会社製)に接種し、30’Cで2日間培養し、第1表
に示す成分からなる基本寒天培地(A)と、酢酸ナトリ
ウム3水和物を59/j2を含む基本寒天培地(B)に
各々レプリカした。
Example 1 A, (PDC activity decrease number obtained) Torulopsis glabrata IFO0005 (requiring cotic acid, thiamine, pyridoxine, and biotin) was subjected to EMS treatment (1 W/V%, 3 hours at 30°C) using a conventional method. Afterwards, it was inoculated onto a nutrient agar medium (GP agar medium, manufactured by Daigo Nutrient Chemical Co., Ltd.), and cultured at 30'C for 2 days. Each hydrate was replicated onto a basic agar medium (B) containing 59/j2.

次に30’Cで3日間培養した本寒天培地(B)での生
育が基本寒天培地(A)での生育より有意によいコロニ
ーを釣菌し、第1表に示す成分からなる発酵培地でピル
ビン酸発酵を行いピルビン酸の蓄積■、対糖収率を調べ
収率の向上した株ACn33 (FERMP−9317
)を得た。次にその株ACn33とその親株について、
以下のようにして、PDC活性を測定した。
Next, we collected colonies that grew significantly better on the main agar medium (B) than on the basic agar medium (A) after culturing at 30'C for 3 days, and cultured them in a fermentation medium consisting of the components shown in Table 1. Pyruvate fermentation was carried out to determine the accumulation of pyruvate and the sugar yield, strain ACn33 (FERMP-9317), which showed improved yield.
) was obtained. Next, regarding the strain ACn33 and its parent strain,
PDC activity was measured as follows.

B、(PDC活性の測定) 第1表に示す基本培地を500m1の坂ロフラスコに1
00dづつ分注し、115℃で15分間滅菌し、培地に
試験菌株IFO0005およびACII33を各々接種
し、30℃で30時間振とう培養した。培養液から菌体
を分離し、pH7,2の0.2 Mカリウム−リン酸緩
衝液で2回洗浄し、上記緩衝液10mに懸濁し、超音波
処理(20分間)し、遠心分離して不溶分を除き、得ら
れた上清を酵素液とした。
B. (Measurement of PDC activity) Add the basal medium shown in Table 1 to a 500 ml Sakaro flask.
The test strains IFO0005 and ACII33 were each inoculated into the culture medium, and cultured with shaking at 30°C for 30 hours. The bacterial cells were separated from the culture solution, washed twice with 0.2 M potassium-phosphate buffer (pH 7.2), suspended in 10 m of the above buffer, sonicated (20 minutes), and centrifuged. Insoluble matter was removed, and the resulting supernatant was used as an enzyme solution.

次に、第2表に示す酵素反応液を調整し、30℃で20
分間酵素反応を行い、2N塩酸に溶かした0、5mMの
2,4−ジニトロフェニルヒドラジンを1r111加え
、反応を停止し、生成アルデヒドをヒドラゾン化するた
め15分間静置し、メタノールを2ml加えヒドラゾン
化合物を溶解し、高速液体クロマトグラフィーにてアセ
トアルデヒドの2,4−ジニトロフェニルヒドラゾンを
定ω分析した。
Next, prepare the enzyme reaction solution shown in Table 2, and
Enzyme reaction was carried out for 1 minute, 0.5mM 2,4-dinitrophenylhydrazine dissolved in 2N hydrochloric acid was added to stop the reaction, and the aldehyde was left standing for 15 minutes to hydrazonate, and 2ml of methanol was added to convert the hydrazone compound. was dissolved, and 2,4-dinitrophenylhydrazone of acetaldehyde was subjected to constant ω analysis using high performance liquid chromatography.

なお、対照液としてはピルビン酸を除いた反応液を用い
た。
Note that a reaction solution without pyruvic acid was used as a control solution.

第   2   表 結果は第3表に示すごとく、ACII33株のPDC活
性は親株の約1/2に低下している。
Table 2 As shown in Table 3, the PDC activity of strain ACII33 was reduced to about 1/2 of that of the parent strain.

第   3   表 実施例2 (ピルビン°酸の生産) 第1表に示す成分からなる発酵培地に酢酸ナトリウム・
3水和物を5g/l添加した培地を11のマイヤーフラ
スコに40rrIiづつ分注し、115℃で15分間滅
菌した。次に、菌株IF0 0005およびACII3
3を各々−白金耳づつ接種し、30℃で60時間回転娠
とう培養した。培養液中に、生成したピルビン酸を高速
液体クロマトグラフィーにて定mした。結果を第4表に
示す。
Table 3 Example 2 (Production of pyruvic acid) Sodium acetate and
A medium supplemented with 5 g/l of trihydrate was dispensed into 11 Meyer flasks in 40 rrIi portions and sterilized at 115° C. for 15 minutes. Next, strains IF0 0005 and ACII3
3 was inoculated in platinum loops and cultured in rotation at 30°C for 60 hours. The amount of pyruvic acid produced in the culture solution was determined by high performance liquid chromatography. The results are shown in Table 4.

なお、対糖収率は消費グルコースに対するピルビン酸の
1ffiで表わした。
Note that the sugar yield was expressed as 1ffi of pyruvic acid relative to consumed glucose.

第   4   表 第3表の結果より明らかなように、本発明例のトルロプ
シス・グラブラータACn33を用いた方法は、ピルビ
ン酸の蓄積濃度、生成収率ともに親株より顕著に向上し
ている。向上の原因はPDC活性の低下により生成ピル
ビン酸のアセトアルデヒドへの代謝が抑制され、グルコ
ースからピルビン酸への変換率が高まったものと推定さ
れる。
As is clear from the results in Table 4, the method using Torulopsis glabrata ACn33 of the present invention example significantly improves both the accumulated concentration and production yield of pyruvic acid compared to the parent strain. The reason for the improvement is presumed to be that the metabolism of generated pyruvate to acetaldehyde was suppressed due to a decrease in PDC activity, and the conversion rate of glucose to pyruvate increased.

次に、ACn33の培養液200dを除菌後、上澄液に
塩酸を加え、112.0とし、エチルエーテルで抽出し
、次いで苛性ソーダでpHを5゜5に中和した後40℃
で減圧濃縮し5m1程度とした。この濃縮液にエタノー
ルを滴下させピルビン酸ソーダ6.629(純度98%
)を1qだ。
Next, after sterilizing 200 d of the culture solution of ACn33, hydrochloric acid was added to the supernatant to bring the pH to 112.0, extracted with ethyl ether, and then the pH was neutralized to 5.5 with caustic soda and then heated at 40°C.
It was concentrated under reduced pressure to a volume of about 5 ml. Ethanol was added dropwise to this concentrated solution, and sodium pyruvic acid 6.629 (purity 98%) was added.
) is 1q.

〈発明の効果〉 本発明方法によればピルビン酸の蓄積量、収率が向上し
、より安価なピルビン酸の生産が可能になった。
<Effects of the Invention> According to the method of the present invention, the accumulated amount and yield of pyruvic acid have been improved, and it has become possible to produce pyruvic acid at a lower cost.

Claims (1)

【特許請求の範囲】[Claims] トルロプシス(Torulopsis)属に属し、ピル
ビン酸生産能を有し、かつピルベートデカルボキシラー
ゼ活性がその親株よりも低い変異株を培養して、培養液
中にピルビン酸を生成蓄積せしめ、培養液中よりピルビ
ン酸を採取することを特徴とする発酵法によるビルピン
酸の製造法。
A mutant strain belonging to the genus Torulopsis that has the ability to produce pyruvate and has lower pyruvate decarboxylase activity than its parent strain is cultured to produce and accumulate pyruvate in the culture solution. A method for producing virupic acid by a fermentation method characterized by collecting pyruvic acid.
JP9093987A 1987-04-15 1987-04-15 Fermentation method for producing pyruvic acid Expired - Fee Related JPH0740945B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9093987A JPH0740945B2 (en) 1987-04-15 1987-04-15 Fermentation method for producing pyruvic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9093987A JPH0740945B2 (en) 1987-04-15 1987-04-15 Fermentation method for producing pyruvic acid

Publications (2)

Publication Number Publication Date
JPS63258586A true JPS63258586A (en) 1988-10-26
JPH0740945B2 JPH0740945B2 (en) 1995-05-10

Family

ID=14012421

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9093987A Expired - Fee Related JPH0740945B2 (en) 1987-04-15 1987-04-15 Fermentation method for producing pyruvic acid

Country Status (1)

Country Link
JP (1) JPH0740945B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0389620A1 (en) * 1987-08-21 1990-10-03 Toray Industries, Inc. Process for preparing pyruvic acid by fermentation
WO1999014335A1 (en) * 1997-09-12 1999-03-25 A.E. Staley Manufacturing Company Yeast strains for the production of lactic acid
DE10129711A1 (en) * 2001-06-22 2003-01-09 Forschungszentrum Juelich Gmbh Process for the fermentative production of pyruvate

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0389620A1 (en) * 1987-08-21 1990-10-03 Toray Industries, Inc. Process for preparing pyruvic acid by fermentation
WO1999014335A1 (en) * 1997-09-12 1999-03-25 A.E. Staley Manufacturing Company Yeast strains for the production of lactic acid
DE10129711A1 (en) * 2001-06-22 2003-01-09 Forschungszentrum Juelich Gmbh Process for the fermentative production of pyruvate
DE10129711B4 (en) * 2001-06-22 2007-08-23 Forschungszentrum Jülich GmbH Process for the fermentative production of pyruvate

Also Published As

Publication number Publication date
JPH0740945B2 (en) 1995-05-10

Similar Documents

Publication Publication Date Title
CN109266707B (en) Method for preparing polysialic acid
JPS63258586A (en) Production of pyruvic acid by fermentation
EP0389620B1 (en) Process for preparing pyruvic acid by fermentation
JP2692457B2 (en) Production of pyruvate by fermentation
JPS6262156B2 (en)
JP2000041689A (en) Production of inositol
JPH1042883A (en) Production of inositol and collection of strain resistant to 6-halogeno-6-deoxyglucose
JPH1042860A (en) Production of inositol and acquirement of hexachlorocyclohexane-resistant strain
JPS5923794B2 (en) Manufacturing method of dihydroxyacetone
JP2002281993A (en) Method for producing shikimic acid
JPH0424038B2 (en)
JPH02308795A (en) Production of pyruvic acid by fermentation method
JPH0838188A (en) Production of inositol and method for taking glucose metabolism antagonistic substance-resistant strain
JPS63258587A (en) Production of pyruvic acid by fermentation
JPS5816692A (en) Preparation of l-tryptophan by enzyme
JPS62275688A (en) Production of pyruvic acid by fermentation
JPS6228678B2 (en)
JP3718572B2 (en) Method for producing malonic acid derivative
JPS6244915B2 (en)
JP3289349B2 (en) Method for producing D-alanine by fermentation method
JPWO2003062437A1 (en) Method for producing α-hydroxy acid ammonium salt
KR20130017800A (en) Mutants of lactobacillus coryniformis producing d-lactic acid with high concentration, high yield, and high purity and their uses
JP2000078967A (en) Microorganism belonging to citrobacter and production of shikimic acid
JPH0424037B2 (en)
JPH01309691A (en) Production of d-alanine

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees